We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Hazards May Diminish the Benefits of Statin Use

By LabMedica International staff writers
Posted on 09 Feb 2009
Authors of a recent paper reviewed the available literature on the adverse effects caused by the use of the statin class of cholesterol reducing drugs and suggested that damage caused to mitochondria may have been the underlying reason for statin-related problems.

Investigators at the University of California, San Diego (La Jolla, USA) examined results from more than 900 studies that described statin (HMG-CoA reductase inhibitors) side effects. More...
They found that the majority of adverse effects were linked to muscle injury with rhabdomyolysis being the most serious complication.

Side effects were found to increase with statin potency, often through inhibition of the mitochondrial cytochrome P450 3A4 system. Additional risk factors for the development of statin side effects were those linked to mitochondrial or metabolic vulnerability, such as metabolic syndrome factors, thyroid disease, and genetic mutations linked to mitochondrial dysfunction.

The review, which appeared in the December 2008 online edition of the American Journal of Cardiovascular Drugs, found that many physicians were unaware not only of the possibility of muscle damage but also of other statin side effects such as cognitive loss, neuropathy, pancreatic and hepatic dysfunction, and sexual dysfunction.

"Physician awareness of such side effects is reportedly low," said first author Dr. Beatrice Golomb, associate professor of medicine at the University of California, San Diego. "Being vigilant for adverse effects in their patients is necessary in order for doctors to provide informed treatment decisions and improved patient care. Muscle problems are the best known of statin drugs' adverse side effects, but cognitive problems and peripheral neuropathy, or pain or numbness in the extremities like fingers and toes, are also widely reported. The risk of adverse effects goes up as age goes up, and this helps explain why statins' benefits have not been found to exceed their risks in those over 70 or 75 years old, even those with heart disease."

Related Links:
University of California, San Diego




Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Automated Staining Unit
RAL Stainer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.